Upgrade to SI Premium - Free Trial

Biogen (BIIB) PT Raised to $200 at BofA Securities

April 24, 2026 3:38 PM
BofA Securities analyst Jason Zemansky raised the price target on Biogen (NASDAQ: BIIB) to $200.00 (from $197.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change